Beckman Coulter, Inc. Announces Results Of The Tender Offer For Its 7.45% Senior Notes Due 2008

FULLERTON, Calif., Dec. 19 /PRNewswire-FirstCall/ -- Beckman Coulter, Inc. , today announced the result of the tender offer for any and all of its outstanding $240 million 7.45% Senior Notes due 2008, which expired at 5:00 p.m. New York City time, on Tuesday, December 19, 2006.

(Logo: http://www.newscom.com/cgi-bin/prnh/20031202/BECLOGO )

A total of $235,101,000 aggregate principal amount of notes was validly tendered in the offer and accepted for payment by us in the tender offer and we will pay for all such tendered notes on December 20, 2006. The offer was contingent upon meeting certain conditions described in the Offer to Purchase dated December 11, 2006 and all of the conditions have been met.

As previously announced, we will pay a purchase price of $1,024.74 plus $21.94 of accrued and unpaid interest per $1,000 principal amount of notes validly tendered pursuant to the offer. We intend to redeem the remaining $4,899,000 of outstanding notes pursuant to the indenture for the notes.

Beckman Coulter, Inc. is a leading manufacturer of biomedical testing instrument systems, tests and supplies that simplify and automate laboratory processes. Spanning the biomedical testing continuum -- from pioneering medical research and clinical trials to laboratory diagnostics and point-of-care testing -- Beckman Coulter's 200,000 installed systems provide essential biomedical information to enhance health care around the world. The company, based in Fullerton, California, reported 2005 annual sales of $2.44 billion with 71.5 percent of this amount generated by recurring revenue from supplies, test kits, services and operating-type lease payments. For more information, visit www.beckmancoulter.com.

Contact: Robert Raynor (714) 773-7620 Director, Investor Relations

CONTACT: Robert Raynor, Director, Investor Relations, Beckman Coulter,Inc., +1-714-773-7620

Web site: http://www.beckmancoulter.com/